| |
| |
|
| Insider
Information: |
Patel Sunil |
| Relationship: |
Director |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
253,085 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,009,966 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
253,085 |
|
|
| Total
Value |
$3,009,966 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
4
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-4.0
|
| Percentage
Gain/Loss : |
 68.9%
|
 -194.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Former Director |
2022-11-01 |
28,820 |
2010-10-07 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2023-01-30 |
224,265 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,753 |
224,265 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-09 |
4 |
B |
$2.77 |
$119,110 |
D/D |
43,000 |
215,512 |
2.39 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Former Director |
– – – |
2022-11-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,004) |
28,820 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
172,512 |
172,512 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,004 |
29,824 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
630 |
28,820 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2020-11-02 |
4 |
B |
$82.52 |
$82,520 |
D/D |
1,000 |
28,190 |
2.39 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
831 |
27,190 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-08-02 |
4 |
B |
$95.98 |
$95,980 |
D/D |
1,000 |
26,359 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
25,359 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-08-16 |
4 |
S |
$240.05 |
$10,150,808 |
D/D |
(42,287) |
24,524 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-08-16 |
4 |
OE |
$9.60 |
$451,058 |
D/D |
27,005 |
66,811 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
39,806 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
666 |
39,313 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
622 |
38,647 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
925 |
38,025 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2015-03-19 |
4 |
S |
$74.42 |
$341,662 |
D/D |
(4,591) |
37,100 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,151 |
41,691 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2013-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,318 |
40,540 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,517 |
36,222 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-05-23 |
4 |
B |
$11.35 |
$17,070 |
D/D |
1,500 |
29,705 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-11-10 |
4 |
B |
$11.11 |
$27,774 |
D/D |
2,500 |
28,205 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-10 |
4 |
B |
$10.72 |
$53,705 |
D/D |
5,000 |
25,705 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,372 |
20,705 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-02-16 |
4 |
B |
$9.18 |
$92,174 |
D/D |
10,000 |
13,333 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
